San Francisco, California-based Qualio, founder and CEO Robert Fenton, has developed a cloud platform to automate these quality control checks. “We do that by solving for the biggest data fragmentation problem that these companies have, which is their quality data. On Tuesday, Qualio announced a $50 million Series B financing round led by Tiger Global. Menlo Ventures also participated in the round, along with returning investors, Storm Ventures, MHS Capital, Sorenson Ventures, Frontline Ventures, and Operator Partners. While some of the world’s biggest pharmaceutical companies have enterprise systems, Qualio is specifically focused on helping small- to mid-sized companies, says Sanday.

Source: Forbes May 25, 2021 09:33 UTC